FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to benzo-[a] -quinolinone of the formula (I) where R is H, alkyl or phenalkyl; Z and Z' - are H, alkyl or one of Z and Z' with R5 forms a bond carbon-carbon Y is H or methyl or with SSS forms a band carbon-carbon; R1 is H or forms a bond carbon-carbon with one of Y or R3; R2 is H or C1-4 alkyl; R3 is H or R1 forms a bond carbon-carbon; R4 is H or with R5 forms a bond carbon-carbon; R5 is H or with one of Z or Z' forms a bond carbon-carbon; n = 1 or 2; X is H, halogen, NO2, cyano-group, CF3, C1-6-alkyl, alkoxy-, carboxy-, alkoxycarbonyl-, amino-, amido-group or a group -A-O-R6 where A is C1-6-alkylene, C2-6-alkenyl or C2-6-alkynylene; R6 - halogen, hydroxy, alkylamido-group or its pharmaceutically acceptable salt. Compounds of the formula (I) are selective steroid inhibitors of 5α--reductase showing strong effect and can be used for treatment of patients with prostate benignity tumors, alopecia, acnes and seborrhea in males. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 19 cl, 1 tbl, 69 ex
Title |
Year |
Author |
Number |
BENZO[F]QUINOLINONE, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1995 |
- Dzhejms Ehdmund Audia
- Kevin Li Khehl
- Tomas Dzhozef Kress
- Loretta Ehjms Makkvejd
- Blehjk Li N'Jubauehr
- Vinsent Patrik Rokko
- Dzhejms Patrik Vepsik
|
RU2172312C2 |
NAPHTHYL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE SUBSTANCES |
1996 |
|
RU2167849C2 |
USE OF 6-HETEROCYCLO-4-AMINO-1,3,4,5-TETRAHYDROBENZ[CD]INDOLE USED IN VOMITING OR NAUSEA AT MOVING, PHARMACEUTICAL COMPOSITION |
1993 |
- Richard Nolan Bukher
- Majkl Ehdvard Flof
- Dehvid Ehrnst Lokhorn
- Charl'Z Dzhon Paget
- Dzhon Menert Shos
|
RU2138262C1 |
(S,S)-N-(2-HYDROXYCYCLOPENTYL)-1-ISOPROPYL-6-METHYLERGOLINE-8- -CARBOXAMIDE OR (S,R)-N-(2-HYDROXYCYCLOPENTYL)-1-ISOPROPYL-6- -METHYLERGOLINE-8-CARBOXAMIDE, THEIR HYDRATES OR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS |
1992 |
- Marlin Lois Kokhen[Us]
- Dehvid Vejn Robertson[Us]
|
RU2086551C1 |
DERIVATIVES OF NAPHTHALENE AND DIHYDRONAPHTHALENE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHODS OF TREATMENT AND INTERMEDIATES SUBSTANCES |
1996 |
- Dzheffri Alan Dodzh
- Kennan Dzhozef Fehjkhi
- Charl'Z Dehvid Dzhouns
- Charl'Z Uillis Lugar
|
RU2167158C2 |
METHOD FOR MINIMIZATION OF HYSTEROTROPHIC EFFECT OF TAMOXYPHENE AND ANALOGS THEREOF |
1995 |
- Genri Ul'Man Brajant
- Stiven Ehntoni Fontana
|
RU2158589C2 |
TRIPEPTIDE DERIVATIVES AS R- OR RS-FORMS OR THEIR PHARMACEUTICALLY ACCEPTABLE NONTOXIC SALTS, PHARMACEUTICAL COMPOSITION |
1991 |
- Paul Dehvid Gesellchen[Us]
- Robert Teodor Shuman[Us]
|
RU2077538C1 |
METHOD OF TREATMENT OR PROPHYLAXIS OF VERTEBRATES ANIMAL FROM PARASITES (VARIANT), COMPOSITION USEFUL FOR TREATMENT OR PROPHYLAXIS OF ANIMALS FROM PARASITES (VARIANTS), COMPOUND OF DISULFONYLMETHANE, DISULFONYLMETHANE COMPOUND SALT |
1993 |
|
RU2133091C1 |
DERIVATIVES OF RHODANINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, USE AS HYPOGLYCEMIC AGENTS AND FOR TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE |
1993 |
- Dzhuliana Maud B'Ju-Valleskej
- Dehvid Charl'Z Khanden
- Charl'Z Dehvid Dzhons
- Dzhill Ehnn Panetta
- Uolter Norman Shou
|
RU2131251C1 |
METHOD OF SYNTHESIS OF 5-SUBSTITUTED PYRROLO[2,3-α]- -PYRIMIDINES |
1993 |
- Charl'Z Dzhekson Barnett
- Tomas Majkl Vilson
|
RU2127274C1 |